local_hospital

Dinox GmbH

Address
lock Available on a paid plan

Reproductive Health and Contraception

At Dinox GmbH in Berlin, clinical research in female urogenital diseases and reproductive physiology includes studies focused on contraceptive effectiveness and the stability of ovulation inhibition when treatment schedules are not followed exactly.

  • Maintenance of ovulation suppression after intentional intake or application errors
  • Evaluation of contraceptive reliability in healthy subjects
  • Research on how delayed or missed use may affect protection

These trials help assess whether new or existing contraceptive approaches can continue to work as intended under real-world use conditions.

Postmenopausal Vaginal Health

Another key area of research at this site is vaginal atrophy in postmenopausal women, with studies examining treatments intended to improve comfort, tissue health, and related symptoms.

  • Changes in vaginal tissue appearance and cytologic patterns
  • Effects on vaginal pH and local vaginal environment
  • Testing treatment benefit for vaginal atrophy and menopausal discomfort

The goal is to better understand how hormonal therapies may support vaginal health and ease symptoms associated with menopause.

Menopause-Related Symptoms and Hair Loss

Clinical trials also explore physiological processes linked to postmenopausal women with vasomotor menopausal symptoms and female pattern hair loss, assessing whether treatment can improve symptom burden and visible hair outcomes.

  • Hair growth measures in women with female pattern hair loss
  • Safety and tolerability of treatment in postmenopausal participants
  • Assessment of effects on the endometrium and bleeding patterns

These studies are designed to evaluate both symptom relief and overall treatment safety, supporting better care options for women after menopause.

Hormonal Treatment Research

The site’s broader research portfolio includes work on reproductive and urinary physiological phenomena, with attention to how hormone-based therapies act in the body and how they may be used to test new treatment options.

  • Assessment of systemic exposure to hormonal therapy
  • Evaluation of local and overall treatment effects
  • Testing new approaches for women’s health conditions

Overall, the studies at Dinox GmbH combine contraception, menopause care, and vaginal health research to improve understanding of women’s health treatments.

Site Overview

assignment
4
connected trials
corporate_fare
3
sponsors
science
3
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
1
Trials started 6–12 months ago
4
Total trials linked
Moderately Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
3
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
4
Outperforms 67% of sites
public
Therapeutic diversity
3areas
Outperforms 79% of sites
groups
Sponsor diversity
3sponsors
Outperforms 65% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Dinox GmbH

lock Showing 1 of 4 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A single-centre, open-label, randomised, phase II study on the maintenance of ovulation inhibition after intentional application errors during 84 days of treatment with MR-130A-01 contraceptive transdermal patchMylan Pharmaceuticals Inc.Phase IINot RecruitingDec 2025

IMP list

lock Showing 1 of 3 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Estriol1Unknown2025-07-162025-07-16

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.